The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis

Rheumatology

Volumn 44, Issue 3, 2005, Pages 293-298

  Chang, X ^a   Yamada, R ^a   Sawada, T ^b   Suzuki, A ^a   Kochi, Y ^a,b   Yamamoto, K ^a,b  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antithrombin; Citrullination; Peptidylarginine deiminase 4 (PAD14); Rheumatoid arthritis; Thrombin

Indexed keywords

ANTITHROMBIN; CITRULLINE; FIBRIN; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE 4; RECOMBINANT ENZYME; THROMBIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRIN DEPOSITION; FIBRIN FORMATION; HUMAN; INCUBATION TIME; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RABBIT; RHEUMATOID ARTHRITIS; WESTERN BLOTTING;

ANIMALS; ANTITHROMBINS; ARTHRITIS, RHEUMATOID; CITRULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROLASES; MUSCLES; RABBITS; RECOMBINANT PROTEINS; THROMBIN;

EID: 14944379544     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh473     Document Type: Article

References (27)

1. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003;25:1106-18.
2. Suzuki A, Yamada R, Chang X et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003;24: 395-402.
3. Pike RN, Potempa J, Skinner R et al. Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity. J Biol Chem 1997;272: 19652-5.
4. Fenton JW 2nd, Ofosu FA, Brezniak DV, Hassouna HI. Thrombin and antithrombotics. Semin Thromb Hemost 1998;24:87-91.
5. Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis 2002;13:657-70.
6. Carmassi F, de Negri F, Morale M, Song KY, Chung SI. Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: a model for extravascular fibrinolysis. Semin Thromb Hemost 1996;22:489-96.
7. Weinberg JB, Pippen AM, Greenberg CS. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991;34:996-1005.
8. Kummer JA, Abbink JJ, De Boer JP. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Arthritis Rheum 1992;35:884-93.
9. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
10. Tsopanoglou NE, Maragoudakis MEJ. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. Biol Chem 1999;274:23969-76.
11. Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans 2002;30:173-7.
12. Maragoudakis ME, Kraniti N, Giannopoulou E, Alexopoulos K, Matsoukas J. Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists. Endothelium 2001;8: 195-205.
13. Koch AE. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998;41:951-62.
14. Walsh DA. Angiogenesis and arthritis. Rheumatology 1999;38:103-12.
15. Brenchley PE. Angiogenesis in inflammatory joint disease: a target for therapeutic intervention. Clin Exp Immunol 2000;121:426-9.
16. Esmon CT. Role of coagulation inhibitors in inflammation. Thromb Haemost 2001;86:51-6.
17. Varisco PA, Peclat V, van Ness K, Bischof-Delaloye A, So A, Busso N. Effect of thrombin inhibition on synovial inflammation in antigen induced arthritis. Ann Rheum Dis 2000;59:781-7.
18. Vossenaar ER, Radstake TR, Van Der Heijden A et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63:373-81.
19. Chang X, Yamada R, Suzuki A et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology Advance Access published October 5, 2004, 10.1093/rheumatology/keh414.
20. Jones HW, Bailey R, Zhang Z et al. Inactivation of antithrombin III in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1998;57:162-5.
21. Ohba T, Takase Y, Ohhara M, Kasukawa R. Thrombin in synovial fluid of patients with rheumatoid arthritis mediates proliferation of synovial fibroblast-like cells by induction of plate derived growth factor. J Rheumatol 1996;23:1505-11.
22. So AK, Varisco PA, Kemkes-Matthes B et al. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 2003;1:2510-15.
23. Chang P, Aronson DL, Borenstein DG, Kessler CM. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation. Am J Hematol 1995;50:79-83.
24. Carrell RW, Owen MC. Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature 1985;317:730-2.
25. Fusegawa H, Ichikawa Y, Tanaka Y et al. [Regulation of coagulofibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus.] Ryumachi 1990;30:90-8 (in Japanese).
26. Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med 2002;126:1326-36.
27. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001;166:4177-84.